[{"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-001", "question": "A 27-year-old G1P0 at 9 weeks' gestation presents with intractable nausea and vomiting, 7-kg weight loss, new-onset jaundice, and confusion over 3 days. She has no prior liver disease or alcohol use. Vitals: T 37.2°C, HR 122, BP 100/62, RR 18, SpO2 98% RA. Exam: scleral icterus, moderate right upper quadrant tenderness without rebound, asterixis. Labs: Na 132, K 3.1, bicarbonate 19, creatinine 1.2 mg/dL (baseline 0.6), AST 545 U/L, ALT 510 U/L, ALP 225 U/L, total bilirubin 12.4 mg/dL (direct 8.1), INR 2.6, ammonia 102 µmol/L, β-hCG markedly elevated for gestational age, thyroid studies: TSH low, free T4 and T3 mildly elevated. Abdominal ultrasound: single live intrauterine pregnancy, normal hepatic and portal vasculature, no biliary dilation, mild fatty liver change. Viral hepatitis serologies and autoimmune markers are pending. She is receiving IV fluids and antiemetics but continues to deteriorate neurologically. Which of the following is the most appropriate immediate next management step?", "options": ["Administer high-dose IV methylprednisolone and defer pregnancy decisions until serologies return", "Urgently proceed with uterine evacuation and initiate N-acetylcysteine infusion", "Start high-dose IV thiamine and parenteral nutrition while continuing pregnancy", "List for emergent liver transplantation without altering pregnancy status", "Administer propylthiouracil and beta-blockers to treat probable gestational thyrotoxicosis and reassess"], "answer": "B", "answer_index": 1, "explanation": "This presentation is most consistent with hyperemesis gravidarum-associated acute liver failure with encephalopathy and coagulopathy; maternal survival takes precedence, and rapid uterine evacuation plus N-acetylcysteine offers the best chance to reverse fulminant hepatic injury. Steroids (A) address autoimmune hepatitis, which is unconfirmed and too slow. Thiamine and nutrition (C) are supportive but insufficient in fulminant failure with encephalopathy. Immediate transplantation listing (D) may be needed but should follow rapid removal of the precipitating factor. Treating mild gestational thyrotoxicosis alone (E) will not address the primary life-threatening hepatic process.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include early gestation with intractable nausea/vomiting, significant weight loss, new jaundice, confusion, asterixis indicating encephalopathy, markedly elevated AST/ALT/bilirubin/INR/ammonia, mild thyrotoxicosis, high β-hCG, mild fatty liver on ultrasound, and neurological deterioration despite supportive care; these point to hyperemesis gravidarum (HG)-associated acute liver failure (ALF), where pregnancy termination is critical to halt progression. Main logical issue(s): None; the stem provides sufficient discriminating findings (e.g., absence of prior liver disease, normal vasculature, pending serologies) to identify B as uniquely best without contradictions or underspecification, as alternatives fail to address the precipitating pregnancy factor urgently. Main medical accuracy issue(s): Overall consistent with standards; HG can cause ALF with encephalopathy, and termination is indicated in life-threatening cases per obstetric guidelines; NAC is supported for non-acetaminophen ALF to improve outcomes, though evidence is stronger in acetaminophen cases; mild gestational thyrotoxicosis is hCG-mediated and secondary, not primary. Minimal fix: Add 'non-acetaminophen' to option B for precision, emphasizing off-label but evidence-based use in pregnancy-related ALF.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include early gestation with intractable nausea/vomiting, significant weight loss, new jaundice, confusion, asterixis indicating encephalopathy, markedly elevated AST/ALT/bilirubin/INR/ammonia, mild thyrotoxicosis, high β-hCG, mild fatty liver on ultrasound, and neurological deterioration despite supportive care; these point to hyperemesis gravidarum (HG)-associated acute liver failure (ALF), where pregnancy termination is critical to halt progression. Main logical issue(s): None; the stem provides sufficient discriminating findings (e.g., absence of prior liver disease, normal vasculature, pending serologies) to identify B as uniquely best without contradictions or underspecification, as alternatives fail to address the precipitating pregnancy factor urgently. Main medical accuracy issue(s): Overall consistent with standards; HG can cause ALF with encephalopathy, and termination is indicated in life-threatening cases per obstetric guidelines; NAC is supported for non-acetaminophen ALF to improve outcomes, though evidence is stronger in acetaminophen cases; mild gestational thyrotoxicosis is hCG-mediated and secondary, not primary. Minimal fix: Add 'non-acetaminophen' to option B for precision, emphasizing off-label but evidence-based use in pregnancy-related ALF.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-002", "question": "A 63-year-old man with long-standing hypertension and ischemic cardiomyopathy (EF 30%) presents with acute right hemiplegia and aphasia 45 minutes after symptom onset. NIHSS is 18. Noncontrast CT head shows no hemorrhage. CT angiography shows left M1 occlusion with favorable collaterals; CT perfusion suggests a large salvageable penumbra. ECG shows sinus rhythm with frequent PVCs. High-sensitivity troponin is mildly elevated and flat on serial testing. You plan IV thrombolysis and urgent mechanical thrombectomy. Which of the following additional acute management steps is most appropriate?", "options": ["Initiate IV unfractionated heparin infusion before mechanical thrombectomy due to high cardioembolic risk", "Administer IV labetalol to reduce blood pressure to <140/90 mm Hg prior to thrombolysis", "Start high-dose statin and delay any antiplatelet therapy until 24 hours after thrombolysis", "Begin dual antiplatelet therapy with aspirin and clopidogrel immediately after thrombolysis", "Place an intra-aortic balloon pump preemptively to support cerebral perfusion during thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "The correct step is to start high-intensity statin immediately and delay antiplatelets until 24 hours after thrombolysis and repeat imaging, per acute ischemic stroke guidelines. Heparin before thrombectomy (A) increases hemorrhagic risk with no proven benefit. Lowering BP below 140/90 (B) before tPA is too aggressive and can worsen cerebral perfusion; only treat if >185/110 to that threshold. Dual antiplatelets immediately after tPA (D) markedly increases hemorrhage risk. Intra-aortic balloon pump (E) has no role in this setting and carries procedural risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: Acute ischemic stroke with LVO (left M1 occlusion), planned IV thrombolysis and mechanical thrombectomy; history of hypertension and ischemic cardiomyopathy (EF 30%) implying atherosclerotic disease; no hemorrhage on CT, good collaterals and penumbra; sinus rhythm with PVCs and mild flat troponin elevation. These support secondary prevention with high-intensity statin initiation (atherosclerotic etiology) while delaying antiplatelets 24 hours post-thrombolysis to minimize hemorrhage risk, aligning with AHA/ASA guidelines. Main logical issue(s), if any: None; stem provides sufficient details for discrimination without contradictions or underspecification, allowing C as uniquely defensible. Alternatives inferior: A increases bleed risk without benefit; B risks hypoperfusion (BP target pre-tPA is <185/110, not <140/90); D heightens hemorrhage; E lacks indication and adds risk. Main medical accuracy issue(s), if any: None; reflects current standards for statin use in AIS with atherosclerosis and antiplatelet delay post-tPA. Minimal fix: None needed; item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: Acute ischemic stroke with LVO (left M1 occlusion), planned IV thrombolysis and mechanical thrombectomy; history of hypertension and ischemic cardiomyopathy (EF 30%) implying atherosclerotic disease; no hemorrhage on CT, good collaterals and penumbra; sinus rhythm with PVCs and mild flat troponin elevation. These support secondary prevention with high-intensity statin initiation (atherosclerotic etiology) while delaying antiplatelets 24 hours post-thrombolysis to minimize hemorrhage risk, aligning with AHA/ASA guidelines. Main logical issue(s), if any: None; stem provides sufficient details for discrimination without contradictions or underspecification, allowing C as uniquely defensible. Alternatives inferior: A increases bleed risk without benefit; B risks hypoperfusion (BP target pre-tPA is <185/110, not <140/90); D heightens hemorrhage; E lacks indication and adds risk. Main medical accuracy issue(s), if any: None; reflects current standards for statin use in AIS with atherosclerosis and antiplatelet delay post-tPA. Minimal fix: None needed; item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-003", "question": "A 34-year-old woman with SLE (malar rash, arthritis, class III lupus nephritis on biopsy) on mycophenolate and low-dose prednisone presents with 3 months of progressive exertional dyspnea and dry cough. She has no smoking history. Vitals: HR 96, BP 112/70, RR 18, SpO2 94% RA. Exam: fine bibasilar crackles, no peripheral edema. Labs: creatinine 1.0 mg/dL, ANA 1:640 homogeneous, anti-dsDNA mildly elevated, complements low, ESR 18 mm/hr, CRP 2 mg/L. PFTs: FVC 65% predicted, FEV1/FVC 0.82, DLCO 40% predicted. HRCT: diffuse ground-glass opacities with scattered areas of consolidation and traction bronchiectasis, predominantly in lower lobes, no honeycombing. BAL: lymphocytic predominance, cultures negative. Echocardiogram: normal LV function, PASP 30 mm Hg. Which of the following is the most appropriate next step in management?", "options": ["Escalate mycophenolate dose and add high-dose oral prednisone without further diagnostics", "Switch mycophenolate to cyclophosphamide and simultaneously list for lung transplantation", "Perform surgical lung biopsy to distinguish organizing pneumonia from NSIP", "Add rituximab while continuing mycophenolate at the same dose", "Initiate nintedanib in addition to current immunosuppression for progressive fibrosing ILD"], "answer": "E", "answer_index": 4, "explanation": "This is SLE-associated progressive fibrosing interstitial lung disease with traction bronchiectasis and physiologic restriction despite immunosuppression; nintedanib has evidence for slowing decline in progressive fibrosing ILDs, including CTD-ILD. Blind escalation of steroids/mycophenolate (A) risks toxicity without clear additional benefit. Routine upfront lung transplant listing (B) is premature. Lung biopsy (C) is high risk and unlikely to alter management given established CTD-ILD pattern. Rituximab (D) can be considered, but antifibrotic therapy specifically targets the progressive fibrosing phenotype and is strongly indicated here.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: SLE with class III nephritis on mycophenolate/prednisone, progressive dyspnea/cough despite therapy, bibasilar crackles, restrictive PFTs with low DLCO, HRCT showing GGO, consolidation, lower-lobe traction bronchiectasis (indicating fibrosis) without honeycombing, lymphocytic BAL without infection, normal echo ruling out PH, low inflammatory markers (ESR/CRP) suggesting no active systemic flare. These point to progressive fibrosing SLE-ILD, where adding antifibrotic nintedanib (E) is the targeted next step per evidence for slowing FVC decline in CTD-associated progressive ILD. Main logical issue(s): None; stem provides sufficient details for discrimination without contradictions or underspecification, supporting E as uniquely best. Alternatives are inferior: A risks unnecessary toxicity without flare evidence; B is overly aggressive/premature; C adds high-risk procedure unlikely to change management in established CTD-ILD; D addresses immunosuppression but not specifically fibrosis. Main medical accuracy issue(s): None; aligns with current guidelines (e.g., INBUILD trial data for nintedanib in progressive fibrosing ILD including SARDs), realistic vignette, accurate pathophysiology. Minimal fix: None needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: SLE with class III nephritis on mycophenolate/prednisone, progressive dyspnea/cough despite therapy, bibasilar crackles, restrictive PFTs with low DLCO, HRCT showing GGO, consolidation, lower-lobe traction bronchiectasis (indicating fibrosis) without honeycombing, lymphocytic BAL without infection, normal echo ruling out PH, low inflammatory markers (ESR/CRP) suggesting no active systemic flare. These point to progressive fibrosing SLE-ILD, where adding antifibrotic nintedanib (E) is the targeted next step per evidence for slowing FVC decline in CTD-associated progressive ILD. Main logical issue(s): None; stem provides sufficient details for discrimination without contradictions or underspecification, supporting E as uniquely best. Alternatives are inferior: A risks unnecessary toxicity without flare evidence; B is overly aggressive/premature; C adds high-risk procedure unlikely to change management in established CTD-ILD; D addresses immunosuppression but not specifically fibrosis. Main medical accuracy issue(s): None; aligns with current guidelines (e.g., INBUILD trial data for nintedanib in progressive fibrosing ILD including SARDs), realistic vignette, accurate pathophysiology. Minimal fix: None needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-004", "question": "A 51-year-old woman with poorly controlled type 2 diabetes and prior pelvic radiation for cervical cancer presents with 5 days of fever, worsening lower abdominal pain, and foul vaginal discharge. She is hypotensive and tachycardic. Exam: diffuse lower abdominal tenderness with guarding, necrotic friable tissue at the posterior vaginal fornix with gas bubbles and crepitus extending toward the rectovaginal septum. Labs: WBC 19,000/µL, lactate 4.5 mmol/L, creatinine 2.1 mg/dL. CT abdomen/pelvis with contrast: extensive gas in the pelvis tracking along fascial planes into the perineum, no discrete drainable collection, suspected uterine and vaginal wall necrosis. Blood cultures are drawn, and broad-spectrum IV antibiotics and aggressive fluids are started. Which is the most appropriate next step?", "options": ["Urgent total abdominal hysterectomy with wide radical debridement of necrotic pelvic and perineal tissue", "Percutaneous CT-guided drainage of gas-containing pelvic spaces plus continued maximal antibiotics", "Hyperbaric oxygen therapy as a temporizing measure before any surgical intervention", "Emergent exploratory laparotomy limited to diagnostic assessment and peritoneal lavage", "Conservative management with antibiotics and close ICU monitoring to avoid worsening radiation injury"], "answer": "A", "answer_index": 0, "explanation": "The clinical picture is necrotizing pelvic soft tissue infection (type I Fournier-like process) involving uterus and vagina in a radiated field, requiring immediate radical surgical debridement including hysterectomy. Percutaneous drainage (B) is inadequate for necrotizing fasciitis. Hyperbaric oxygen (C) may be adjunctive but never replaces urgent debridement. Exploratory laparotomy without aggressive debridement (D) fails to control source. Conservative management (E) carries an almost universally fatal risk in necrotizing infections.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: Poorly controlled type 2 diabetes and prior pelvic radiation as risk factors; 5 days of fever, worsening lower abdominal pain, foul vaginal discharge; hypotension, tachycardia, diffuse tenderness with guarding; necrotic friable tissue with gas bubbles and crepitus; leukocytosis, elevated lactate and creatinine; CT showing extensive pelvic gas without discrete drainable collection, suspected uterine/vaginal necrosis. These point to necrotizing pelvic soft tissue infection (e.g., Fournier-like) requiring urgent surgical source control. Main logical issue(s), if any: None; stem provides sufficient discriminating details for a single best answer without contradictions or underspecification, as no discrete collection rules out drainage, and clinical sepsis with necrosis mandates debridement over conservative or limited approaches. Main medical accuracy issue(s), if any: None; aligns with standard care for necrotizing fasciitis, where immediate radical debridement (including hysterectomy if involved) is essential, antibiotics are supportive, hyperbaric oxygen is adjunctive only, and conservative management is contraindicated due to high mortality. Minimal fix: No edit needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: Poorly controlled type 2 diabetes and prior pelvic radiation as risk factors; 5 days of fever, worsening lower abdominal pain, foul vaginal discharge; hypotension, tachycardia, diffuse tenderness with guarding; necrotic friable tissue with gas bubbles and crepitus; leukocytosis, elevated lactate and creatinine; CT showing extensive pelvic gas without discrete drainable collection, suspected uterine/vaginal necrosis. These point to necrotizing pelvic soft tissue infection (e.g., Fournier-like) requiring urgent surgical source control. Main logical issue(s), if any: None; stem provides sufficient discriminating details for a single best answer without contradictions or underspecification, as no discrete collection rules out drainage, and clinical sepsis with necrosis mandates debridement over conservative or limited approaches. Main medical accuracy issue(s), if any: None; aligns with standard care for necrotizing fasciitis, where immediate radical debridement (including hysterectomy if involved) is essential, antibiotics are supportive, hyperbaric oxygen is adjunctive only, and conservative management is contraindicated due to high mortality. Minimal fix: No edit needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-005", "question": "A 76-year-old man with permanent atrial fibrillation on apixaban, CKD stage 3b, and prior TIA undergoes TAVR for symptomatic severe aortic stenosis. Preprocedure echo: EF 55%, no intracardiac thrombus, moderate MAC, mild-moderate MR. Postprocedure, he develops acute severe dyspnea and hypotension 2 hours later. Echo: hyperdynamic LV with near-complete mid-cavity obliteration in systole, peak LVOT gradient 80 mm Hg, systolic anterior motion (SAM) of the mitral valve, severe MR, intact TAVR function. Which of the following is the most appropriate immediate management?", "options": ["Start high-dose IV furosemide and nitroprusside to rapidly reduce preload and afterload", "Administer aggressive IV crystalloids and start a phenylephrine infusion while reducing inotropes", "Urgently return to the cath lab for balloon post-dilatation of the TAVR prosthesis", "Begin IV milrinone infusion to augment contractility and improve forward flow", "Perform emergent surgical myectomy with mitral valve repair"], "answer": "B", "answer_index": 1, "explanation": "This is dynamic LVOT obstruction with SAM and severe MR precipitated by TAVR and low preload; management mirrors hypertrophic obstructive physiology-volume expansion and pure alpha-agonist (phenylephrine) to increase afterload while avoiding inotropes. Diuresis and vasodilators (A) and inotropes (D) worsen obstruction. Post-dilatation of the valve (C) is not indicated as prosthetic function is normal. Emergent surgery (E) is reserved for refractory cases after optimal medical hemodynamic management has failed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include post-TAVR acute dyspnea and hypotension with echo showing hyperdynamic LV, near-complete mid-cavity obliteration, peak LVOT gradient 80 mm Hg, SAM of mitral valve, severe MR, and intact TAVR function. These indicate dynamic LVOT obstruction (LVOTO) mimicking hypertrophic obstructive cardiomyopathy, precipitated by procedural factors like reduced afterload or preload. The keyed answer B (IV crystalloids and phenylephrine, reduce inotropes) appropriately addresses this by expanding volume to increase preload and using alpha-agonism to raise afterload, thereby reducing obstruction and SAM without worsening hypercontractility. Main logical issues: None; the vignette provides sufficient discriminating details (e.g., hyperdynamic state, high gradient, SAM, normal prosthesis) to eliminate alternatives—A worsens with preload/afterload reduction; C is irrelevant as TAVR is intact; D exacerbates with inotropy; E is overly invasive for initial management. Main medical accuracy issues: None; aligns with current guidelines for managing post-TAVR dynamic LVOTO, emphasizing conservative hemodynamic optimization before invasive interventions. Minimal fix: None needed; item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include post-TAVR acute dyspnea and hypotension with echo showing hyperdynamic LV, near-complete mid-cavity obliteration, peak LVOT gradient 80 mm Hg, SAM of mitral valve, severe MR, and intact TAVR function. These indicate dynamic LVOT obstruction (LVOTO) mimicking hypertrophic obstructive cardiomyopathy, precipitated by procedural factors like reduced afterload or preload. The keyed answer B (IV crystalloids and phenylephrine, reduce inotropes) appropriately addresses this by expanding volume to increase preload and using alpha-agonism to raise afterload, thereby reducing obstruction and SAM without worsening hypercontractility. Main logical issues: None; the vignette provides sufficient discriminating details (e.g., hyperdynamic state, high gradient, SAM, normal prosthesis) to eliminate alternatives—A worsens with preload/afterload reduction; C is irrelevant as TAVR is intact; D exacerbates with inotropy; E is overly invasive for initial management. Main medical accuracy issues: None; aligns with current guidelines for managing post-TAVR dynamic LVOTO, emphasizing conservative hemodynamic optimization before invasive interventions. Minimal fix: None needed; item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-006", "question": "A 42-year-old man who injects drugs presents with 10 days of fever, severe back pain, and new right leg weakness. Vitals: T 38.8°C, HR 108, BP 122/74. Exam: midline lumbar tenderness, right leg 3/5 strength with hyperreflexia, left leg 5/5, intact sensation, no bowel/bladder symptoms. Labs: WBC 15,000/µL, ESR 96 mm/hr, CRP 120 mg/L. Blood cultures: MRSA in 2/2 sets. MRI lumbar spine with contrast: dorsal epidural collection L2-L4 with significant canal compromise and enhancement consistent with epidural abscess, plus adjacent vertebral osteomyelitis; no discrete psoas abscess. He is started on IV vancomycin. Neurosurgery feels surgery is high risk due to severe cardiomyopathy (EF 20%) and active drug use, recommending medical therapy unless deterioration. What is the most appropriate next step?", "options": ["Continue IV vancomycin alone with close neurologic monitoring for at least 6 weeks", "Add rifampin to vancomycin to enhance penetration into epidural space and bone", "Perform urgent surgical decompression and drainage despite high perioperative risk", "Switch to daptomycin plus ceftaroline to provide broader MRSA coverage", "Place percutaneous CT-guided drain into the epidural collection to avoid open surgery"], "answer": "C", "answer_index": 2, "explanation": "He has spinal epidural abscess with evolving motor deficit and significant canal compromise; urgent surgical decompression and drainage is indicated despite elevated operative risk, as delay risks permanent paralysis. Medical therapy alone (A, B, D) is inadequate once neurologic deficits are present. Percutaneous drainage (E) is not appropriate for epidural abscess causing cord compression, as it rarely achieves effective decompression or safe access to the epidural space.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: M\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues that drive (or fail to drive) a unique best answer: New right leg weakness (3/5 strength, hyperreflexia) indicating neurologic deficit, MRI showing epidural abscess with significant canal compromise and osteomyelitis, MRSA bacteremia, high surgical risk from severe cardiomyopathy (EF 20%) and active drug use, neurosurgery recommendation for medical therapy unless deterioration.\\nMain logical issue(s): Multiple answers defensible (M) - Option C (urgent surgery despite risk, aligning with standard guidelines for spinal epidural abscess with neuro compromise to prevent permanent damage) and Option A (continue IV vancomycin with monitoring, following neurosurgery's explicit recommendation given prohibitive operative risks). The stem presents conflicting drivers: standard care favors surgery for deficit and cord compression, but specialist opinion and patient risks support initial medical management, leading to no unique best without additional details on deficit progression or risk quantification.\\nMain medical accuracy issue(s): Intended teaching point (surgery for SEA with deficit) is mostly consistent with guidelines (e.g., IDSA), but vignette introduces unrealistic or nonstandard neurosurgery advice against surgery despite present deficit, missing nuance of individualized risk-benefit in high-risk patients where medical therapy is sometimes preferred to avoid perioperative mortality.\\nMinimal fix: Delete the sentence 'Neurosurgery feels surgery is high risk... recommending medical therapy unless deterioration' from the stem to eliminate support for A and make C unambiguously best.\",\n  \"medical_accuracy_score\": 3,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues that drive (or fail to drive) a unique best answer: New right leg weakness (3/5 strength, hyperreflexia) indicating neurologic deficit, MRI showing epidural abscess with significant canal compromise and osteomyelitis, MRSA bacteremia, high surgical risk from severe cardiomyopathy (EF 20%) and active drug use, neurosurgery recommendation for medical therapy unless deterioration.\nMain logical issue(s): Multiple answers defensible (M) - Option C (urgent surgery despite risk, aligning with standard guidelines for spinal epidural abscess with neuro compromise to prevent permanent damage) and Option A (continue IV vancomycin with monitoring, following neurosurgery's explicit recommendation given prohibitive operative risks). The stem presents conflicting drivers: standard care favors surgery for deficit and cord compression, but specialist opinion and patient risks support initial medical management, leading to no unique best without additional details on deficit progression or risk quantification.\nMain medical accuracy issue(s): Intended teaching point (surgery for SEA with deficit) is mostly consistent with guidelines (e.g., IDSA), but vignette introduces unrealistic or nonstandard neurosurgery advice against surgery despite present deficit, missing nuance of individualized risk-benefit in high-risk patients where medical therapy is sometimes preferred to avoid perioperative mortality.\nMinimal fix: Delete the sentence 'Neurosurgery feels surgery is high risk... recommending medical therapy unless deterioration' from the stem to eliminate support for A and make C unambiguously best.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-007", "question": "A 31-year-old woman presents with severe headaches, transient visual obscurations, and pulsatile tinnitus 6 months postpartum. She has gained 20 kg during and after pregnancy. BMI is 38 kg/m². Exam: bilateral papilledema, full strength, no focal deficits. MRI brain with and without contrast is normal. MRV shows smooth tapering and non-visualization of the terminal right transverse sinus with small caliber sigmoid sinus and jugular bulb; the left transverse sinus is dominant and widely patent. Lumbar puncture: opening pressure 34 cm H₂O, normal CSF studies. She is started on acetazolamide and advised weight loss but continues to have progressive visual field loss on serial perimetry over 8 weeks. What is the most appropriate next step in management?", "options": ["Place a ventriculoperitoneal shunt to lower intracranial pressure", "Perform right transverse sinus stenting across the narrowed segment", "Initiate high-dose oral topiramate instead of acetazolamide", "Perform optic nerve sheath fenestration to protect vision", "Start therapeutic anticoagulation for presumed chronic venous sinus thrombosis"], "answer": "D", "answer_index": 3, "explanation": "The patient has idiopathic intracranial hypertension with rapidly progressive visual loss despite maximal medical therapy; optic nerve sheath fenestration is the preferred intervention to promptly protect vision. VP shunting (A) is an option but has higher long-term failure and complication rates and is usually considered after or when ONSF is not feasible. Transverse sinus stenting (B) is usually reserved for documented significant pressure gradients and bilateral or dominant-sided stenosis; here the right sinus is small and nondominant. Topiramate (C) is an adjunct but insufficient alone given progressive visual decline. Anticoagulation (E) is not indicated without imaging evidence of thrombosis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 31-year-old obese postpartum woman with headaches, visual obscurations, tinnitus, papilledema, elevated opening pressure (34 cm H₂O), normal CSF and MRI, MRV showing unilateral non-dominant right transverse sinus narrowing, and progressive visual field loss despite acetazolamide and weight loss advice. These support idiopathic intracranial hypertension (IIH) with failing medical therapy, necessitating intervention for vision protection. Main logical issue(s), if any: None; stem provides sufficient details for discriminating a single best next step without contradictions or underspecification. Main medical accuracy issue(s), if any: None; aligns with current guidelines (e.g., ONSF preferred over shunting for progressive visual loss in IIH per neuro-ophthalmology consensus; stenting reserved for significant bilateral/dominant stenosis with gradients; no thrombosis evidence precludes anticoagulation; topiramate is adjunctive, not replacement for failing therapy). Minimal fix: No edit needed as item is already unambiguous and accurate, but if enhancing, add 'no pressure gradient on venography' to MRV description to further justify avoiding stenting.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 31-year-old obese postpartum woman with headaches, visual obscurations, tinnitus, papilledema, elevated opening pressure (34 cm H₂O), normal CSF and MRI, MRV showing unilateral non-dominant right transverse sinus narrowing, and progressive visual field loss despite acetazolamide and weight loss advice. These support idiopathic intracranial hypertension (IIH) with failing medical therapy, necessitating intervention for vision protection. Main logical issue(s), if any: None; stem provides sufficient details for discriminating a single best next step without contradictions or underspecification. Main medical accuracy issue(s), if any: None; aligns with current guidelines (e.g., ONSF preferred over shunting for progressive visual loss in IIH per neuro-ophthalmology consensus; stenting reserved for significant bilateral/dominant stenosis with gradients; no thrombosis evidence precludes anticoagulation; topiramate is adjunctive, not replacement for failing therapy). Minimal fix: No edit needed as item is already unambiguous and accurate, but if enhancing, add 'no pressure gradient on venography' to MRV description to further justify avoiding stenting.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-008", "question": "A 29-year-old woman with a history of two early first-trimester miscarriages and one unexplained fetal demise at 28 weeks presents for preconception counseling. She has livedo reticularis and episodes of digital ischemia in cold weather. Labs: platelets 110,000/µL, hemoglobin 11.5 g/dL, creatinine 0.9 mg/dL. Coagulation profile is normal. aPTT is mildly prolonged. Lupus anticoagulant is repeatedly positive; anticardiolipin IgG and anti-β2-glycoprotein I IgG are high-titer on two occasions 12 weeks apart. She has no personal history of venous or arterial thrombosis. Which of the following is the most appropriate pregnancy management plan?", "options": ["Low-dose aspirin alone starting preconception, escalate to prophylactic LMWH only if thrombosis occurs", "Therapeutic-dose LMWH plus low-dose aspirin starting at positive pregnancy test and continuing 6 weeks postpartum", "Prophylactic-dose LMWH plus low-dose aspirin starting at conception and stopping at delivery", "Low-dose aspirin only during pregnancy, with postpartum prophylactic LMWH for 6 weeks", "No anticoagulation unless she develops hypertensive disorders of pregnancy"], "answer": "B", "answer_index": 1, "explanation": "She meets criteria for high-risk obstetric antiphospholipid syndrome with recurrent pregnancy loss and triple-positive aPL; therapeutic-dose LMWH plus low-dose aspirin throughout pregnancy and 6 weeks postpartum provides optimal maternal and fetal protection. Aspirin alone (A, D, E) is inadequate in high-risk APS. Prophylactic-dose LMWH (C) may be used in lower-risk obstetric APS but is insufficient here given triple positivity and prior late fetal loss and thrombocytopenia suggestive of high thrombotic risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues driving unique best answer include history of recurrent pregnancy loss (two early miscarriages, one late fetal demise at 28 weeks), clinical signs of livedo reticularis and digital ischemia, thrombocytopenia (110,000/µL), and triple-positive antiphospholipid antibodies (repeated positive lupus anticoagulant, high-titer anticardiolipin IgG, and anti-β2-glycoprotein I IgG) without personal thrombosis history. These establish high-risk obstetric antiphospholipid syndrome (APS), warranting aggressive management to prevent maternal thrombosis and fetal loss. No main logical issues; the vignette is internally consistent, supports a single best answer (B) via clear discrimination among options, and the key matches it without requiring unstated assumptions. No main medical accuracy issues; the implied logic aligns with current guidelines (e.g., EULAR/ACOG recommendations for therapeutic-dose LMWH plus low-dose aspirin in high-risk APS from positive pregnancy test through 6 weeks postpartum). Alternatives are appropriately inferior: A and D provide inadequate anticoagulation during pregnancy; C uses subtherapeutic dosing; E withholds treatment inappropriately. Minimal fix: None needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues driving unique best answer include history of recurrent pregnancy loss (two early miscarriages, one late fetal demise at 28 weeks), clinical signs of livedo reticularis and digital ischemia, thrombocytopenia (110,000/µL), and triple-positive antiphospholipid antibodies (repeated positive lupus anticoagulant, high-titer anticardiolipin IgG, and anti-β2-glycoprotein I IgG) without personal thrombosis history. These establish high-risk obstetric antiphospholipid syndrome (APS), warranting aggressive management to prevent maternal thrombosis and fetal loss. No main logical issues; the vignette is internally consistent, supports a single best answer (B) via clear discrimination among options, and the key matches it without requiring unstated assumptions. No main medical accuracy issues; the implied logic aligns with current guidelines (e.g., EULAR/ACOG recommendations for therapeutic-dose LMWH plus low-dose aspirin in high-risk APS from positive pregnancy test through 6 weeks postpartum). Alternatives are appropriately inferior: A and D provide inadequate anticoagulation during pregnancy; C uses subtherapeutic dosing; E withholds treatment inappropriately. Minimal fix: None needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-009", "question": "A 55-year-old man from a region endemic for Lyme disease presents with 1 week of rapidly progressive bilateral leg weakness and numbness ascending from the feet, severe radicular pain, and new urinary retention. He was treated with oral doxycycline 3 weeks ago for erythema migrans following a hiking trip. Exam: symmetric lower extremity weakness 3/5 proximally and distally, hyperreflexia with bilateral Babinski signs, decreased pinprick below T10, preserved vibration sense in toes, and saddle hypesthesia. Cranial nerves are normal. MRI spine with contrast: multifocal enhancing lesions in the thoracic cord with associated leptomeningeal enhancement; no compressive lesion. CSF: WBC 220/µL (80% lymphocytes), protein 120 mg/dL, glucose 45 mg/dL (serum 90), oligoclonal bands present; CSF Lyme antibody index is elevated. HIV, syphilis, and TB tests are negative. What is the most appropriate treatment?", "options": ["High-dose IV methylprednisolone alone for presumed idiopathic transverse myelitis", "IV ceftriaxone 2 g daily for 4 weeks without steroids", "IV ceftriaxone 2 g daily plus high-dose IV methylprednisolone", "Oral doxycycline 100 mg BID for 28 days plus high-dose oral prednisone taper", "Plasma exchange for 5-7 sessions followed by IV ceftriaxone"], "answer": "B", "answer_index": 1, "explanation": "This is Lyme neuroborreliosis with meningomyelitis confirmed by elevated CSF Lyme antibody index and appropriate clinical picture; standard treatment is prolonged IV ceftriaxone without routine adjunctive steroids. Steroids alone (A) are inappropriate and may worsen infection. Adding high-dose steroids to antibiotics (C) has no proven benefit and may be harmful. Oral doxycycline (D) is inadequate for CNS parenchymal involvement. Plasma exchange (E) is used in severe autoimmune demyelination (e.g., NMO, ADEM) and is not indicated here once Lyme is confirmed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include history of erythema migrans treated with oral doxycycline, progressive ascending bilateral leg weakness with urinary retention, exam findings of symmetric weakness, hyperreflexia, Babinski signs, T10 sensory level with preserved vibration and saddle hypesthesia, MRI showing multifocal enhancing thoracic cord lesions with leptomeningeal enhancement, and CSF with lymphocytic pleocytosis, elevated protein, oligoclonal bands, and elevated Lyme antibody index, all pointing to Lyme neuroborreliosis (meningomyelitis) in an endemic area, with negative tests for differentials like HIV, syphilis, and TB. These clues confirm an infectious etiology requiring targeted antibiotic therapy without adjunctive steroids or other interventions. Main logical issue(s), if any: None; the vignette provides sufficient discriminating details to identify IV ceftriaxone alone as the single best option, with alternatives clearly inferior (A ignores infection; C adds unproven steroids; D uses inadequate oral regimen; E applies autoimmune therapy inappropriately). Main medical accuracy issue(s), if any: None; aligns with IDSA guidelines for CNS Lyme disease, emphasizing IV ceftriaxone monotherapy, avoiding steroids to prevent harm in active infection, and reserving oral doxycycline for early non-CNS disease. Minimal fix: No edit needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include history of erythema migrans treated with oral doxycycline, progressive ascending bilateral leg weakness with urinary retention, exam findings of symmetric weakness, hyperreflexia, Babinski signs, T10 sensory level with preserved vibration and saddle hypesthesia, MRI showing multifocal enhancing thoracic cord lesions with leptomeningeal enhancement, and CSF with lymphocytic pleocytosis, elevated protein, oligoclonal bands, and elevated Lyme antibody index, all pointing to Lyme neuroborreliosis (meningomyelitis) in an endemic area, with negative tests for differentials like HIV, syphilis, and TB. These clues confirm an infectious etiology requiring targeted antibiotic therapy without adjunctive steroids or other interventions. Main logical issue(s), if any: None; the vignette provides sufficient discriminating details to identify IV ceftriaxone alone as the single best option, with alternatives clearly inferior (A ignores infection; C adds unproven steroids; D uses inadequate oral regimen; E applies autoimmune therapy inappropriately). Main medical accuracy issue(s), if any: None; aligns with IDSA guidelines for CNS Lyme disease, emphasizing IV ceftriaxone monotherapy, avoiding steroids to prevent harm in active infection, and reserving oral doxycycline for early non-CNS disease. Minimal fix: No edit needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-010", "question": "A 48-year-old woman with seropositive rheumatoid arthritis (RF and anti-CCP positive) on methotrexate and adalimumab presents with subacute dyspnea and nonproductive cough. She has never smoked. Vitals: HR 104, BP 118/70, RR 22, SpO2 91% RA. Exam: fine bibasilar crackles, no wheezing, active small-joint synovitis. PFTs: FVC 58% predicted, FEV1/FVC 0.86, DLCO 35% predicted. HRCT: basilar-predominant reticulation, traction bronchiectasis, and patchy subpleural honeycombing consistent with usual interstitial pneumonia (UIP); no nodules or pleural effusions. Which of the following is the most appropriate disease-modifying management change?", "options": ["Continue methotrexate and adalimumab and add low-dose prednisone", "Discontinue methotrexate and switch adalimumab to rituximab", "Stop adalimumab and start tocilizumab while continuing methotrexate", "Continue current RA regimen and initiate mycophenolate mofetil for lung disease", "Add nintedanib while continuing methotrexate and adalimumab unchanged"], "answer": "B", "answer_index": 1, "explanation": "She has RA-associated ILD with a UIP pattern, in which methotrexate and TNF inhibitors are relatively contraindicated due to concerns for ILD progression; rituximab is preferred as an RA biologic in ILD. Continuing MTX/TNF with steroids (A) risks worsening lung fibrosis. Tocilizumab (C) has less data and does not address TNF-risk concerns. Adding mycophenolate (D) without removing potential pulmonary offenders is suboptimal. Nintedanib (E) may be beneficial in progressive fibrosing RA-ILD, but first-line is to remove MTX/TNF and choose an ILD-favorable biologic such as rituximab.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include seropositive RA on methotrexate and adalimumab, subacute dyspnea with bibasilar crackles, restrictive PFTs (FVC 58%, DLCO 35%), and HRCT showing UIP pattern (basilar reticulation, traction bronchiectasis, honeycombing), implying RA-associated ILD where MTX and TNF inhibitors risk progression. These support discontinuing MTX, switching from adalimumab to rituximab (B) as the optimal change to an ILD-favorable biologic while managing RA. Alternatives are inferior: A adds steroids without removing risks; C continues MTX; D maintains offenders and adds MMF; E adds nintedanib but ignores potential iatrogenic factors. Main logical issue(s): None; stem provides sufficient details for discriminating B as uniquely best without contradictions or underspecification. Main medical accuracy issue(s): Consistent with current guidelines (e.g., expert consensus preferring rituximab in RA-ILD, caution with MTX/TNF due to progression risks); nintedanib is appropriate for progressive fibrosing ILD but secondary to optimizing DMARDs. Minimal fix: No edit needed; item is unambiguous and accurate as is.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include seropositive RA on methotrexate and adalimumab, subacute dyspnea with bibasilar crackles, restrictive PFTs (FVC 58%, DLCO 35%), and HRCT showing UIP pattern (basilar reticulation, traction bronchiectasis, honeycombing), implying RA-associated ILD where MTX and TNF inhibitors risk progression. These support discontinuing MTX, switching from adalimumab to rituximab (B) as the optimal change to an ILD-favorable biologic while managing RA. Alternatives are inferior: A adds steroids without removing risks; C continues MTX; D maintains offenders and adds MMF; E adds nintedanib but ignores potential iatrogenic factors. Main logical issue(s): None; stem provides sufficient details for discriminating B as uniquely best without contradictions or underspecification. Main medical accuracy issue(s): Consistent with current guidelines (e.g., expert consensus preferring rituximab in RA-ILD, caution with MTX/TNF due to progression risks); nintedanib is appropriate for progressive fibrosing ILD but secondary to optimizing DMARDs. Minimal fix: No edit needed; item is unambiguous and accurate as is.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]